Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Integral Diagnostics Ltd. ( (AU:IDX) ) just unveiled an update.
Integral Diagnostics has scheduled a group investor conference call for 11:00am AEDT on 24 February 2026, to be held following the release of its FY26 half-year financial results earlier that day. The planned briefing underscores the company’s engagement with investors and analysts, offering stakeholders a forum to review the latest performance metrics and operational developments in the context of the competitive medical imaging sector in Australasia.
The most recent analyst rating on (AU:IDX) stock is a Sell with a A$2.10 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics (IDX) is a leading provider of medical imaging services across Australia and New Zealand, employing radiologists and diagnostic imaging specialists under a medical leadership model focused on quality patient care, service, and access.
Average Trading Volume: 866,055
Technical Sentiment Signal: Buy
Current Market Cap: A$969.6M
Learn more about IDX stock on TipRanks’ Stock Analysis page.